1.
The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. Genetics and Mol. Res. [Internet]. 2026 Jan. 5 [cited 2026 Jan. 29];25(1):1-25. Available from: https://geneticsmr.com/index.php/gmr/article/view/205